NCT04195932View on ClinicalTrials.gov

Exercise as a Modulator of Immune Risk Factors for Ischemic Heart Disease

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

December 31, 1996

Primary Completion Date

May 31, 1998

Study Completion Date

May 31, 1998

Conditions
Heart Diseases
Interventions
OTHER

Exercise training

Trial Locations (1)

70571

James H. Quillen College of Medicine, Johnson City

All Listed Sponsors
lead

East Tennessee State University

OTHER

NCT04195932 - Exercise as a Modulator of Immune Risk Factors for Ischemic Heart Disease | Biotech Hunter | Biotech Hunter